SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 1,514.63 |
| Enterprise Value ($M) | 1,593.87 |
| Book Value ($M) | 135.21 |
| Book Value / Share | 0.58 |
| Price / Book | 11.20 |
| NCAV ($M) | 63.04 |
| NCAV / Share | 0.27 |
| Price / NCAV | 24.03 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.10 |
| Return on Assets (ROA) | -0.08 |
| Return on Equity (ROE) | -0.19 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.69 |
| Current Ratio | 5.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 257.01 |
| Assets | 329.18 |
| Liabilities | 193.98 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 258.21 |
| Operating Income | 24.43 |
| Net Income | -28.24 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 8.80 |
| Cash from Investing | -4.98 |
| Cash from Financing | -38.99 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Nuveen Asset Management, LLC | 2.17 | -2.77 | |
| 13G/A | Tiaa Cref Investment Management Llc | 2.17 | -2.77 | |
| 13G/A | Teachers Advisors, Llc | 2.17 | -2.77 | |
| 13G/A | Perceptive Advisors Llc | 2.80 | -45.94 | |
| 13G | Vanguard Group Inc | 5.71 | ||
| 13G/A | BlackRock Inc. | 7.90 | 18.65 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 331,231 | 2,533,785 | 13.07 | |
| 177,882 | 809,577 | 21.97 | |
| 408,609 | 1,291,051 | 31.65 | |
| 482,208 | 1,251,214 | 38.54 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACET – Adicet Bio, Inc. | ACIU – AC Immune SA |
| ACRV – Acrivon Therapeutics, Inc. | ALIM – Alimera Sciences, Inc. |
| ALPN – Alpine Immune Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io